Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Ventricular Dysfunction: early-phase trial registry
1 of 4 indexed Ventricular Dysfunction trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Ventricular Dysfunction: 4 US clinical trials tracked, 1 recruiting.
Ventricular Dysfunction is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Deborah Ascheim, running 1 of these trials.
Enrollment posture brief
Registry condition ventricular-dysfunction
OPEN 1 | RECR 25% | LATE 0 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Ventricular Dysfunction lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Ventricular Dysfunction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Ventricular Dysfunction is recruiting below its size-band peers.
1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
VDI Technologies
NCT06641362
Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination Therapy
Abbott Medical Devices
NCT00121485
Focused Cardiac Ultrasound
University of Miami
NCT03887286
The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in Patients Undergoing LVAD Implantation
Deborah Ascheim
NCT01442129
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Ventricular Dysfunction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Ventricular Dysfunction trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Ventricular Dysfunction page
4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Ventricular Dysfunction trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Deborah Ascheim sponsors the most Ventricular Dysfunction trials on record, review their full trial history before evaluating a specific study. See Deborah Ascheim's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Ventricular Dysfunction condition card totals 4 registered trials; most-linked intervention Control Solution; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.